These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 76749

  • 21. A mechanism for hyporeninemic hypoaldosteronism in chronic renal disease.
    Oh MS, Carroll HJ, Clemmons JE, Vagnucci AH, Levison SP, Whang ES.
    Metabolism; 1974 Dec; 23(12):1157-66. PubMed ID: 4372510
    [No Abstract] [Full Text] [Related]

  • 22. Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.
    Lee SM, Lightner E, Witte M, Oberfield S, Levine L, New MI.
    Acta Endocrinol (Copenh); 1982 Feb; 99(2):251-5. PubMed ID: 6277130
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Hyporeninemic hypoaldosteronism with diabetic glomerulosclerosis.
    Sparagana M.
    Biochem Med; 1975 Sep; 14(1):93-103. PubMed ID: 174560
    [No Abstract] [Full Text] [Related]

  • 25. Plasma aldosterone and renin activity response to ACTH infusion in dexamethasone-suppressed normal and sodium-depleted man.
    Kem DC, Gomez-Sanchez C, Kramer NJ, Holland OB, Higgins JR.
    J Clin Endocrinol Metab; 1975 Jan; 40(1):116-24. PubMed ID: 163263
    [No Abstract] [Full Text] [Related]

  • 26. Hyporeninemic hypoaldosteronism in infancy: a familial disease.
    Landier F, Guyene TT, Boutignon H, Nahoul K, Corvol P, Job JC.
    J Clin Endocrinol Metab; 1984 Jan; 58(1):143-8. PubMed ID: 6315756
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. 17-alpha-hydroxylase deficiency in three siblings: short- and long-term studies.
    Scaroni C, Biason A, Carpenè G, Opocher G, Mantero F.
    J Endocrinol Invest; 1991 Feb; 14(2):99-108. PubMed ID: 1648117
    [Abstract] [Full Text] [Related]

  • 32. Mineralocorticoid-induced kaliuresis in type-II pseudohypoaldosteronism.
    Travis PS, Cushner HM.
    Am J Med Sci; 1986 Oct; 292(4):235-40. PubMed ID: 3529961
    [Abstract] [Full Text] [Related]

  • 33. Treatment of familial hyperaldosteronism type I: only partial suppression of adrenocorticotropin required to correct hypertension.
    Stowasser M, Bachmann AW, Huggard PR, Rossetti TR, Gordon RD.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3313-8. PubMed ID: 10999827
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. 18-Hydroxy-deoxycorticosterone in human hypertension.
    Melby JC, Dale SL, Wilson TE.
    Circ Res; 1971 May; 28(5):Suppl 2:143-52. PubMed ID: 4327960
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
    Fallo F, Pilon C, Williams TA, Sonino N, Morra Di Cella S, Veglio F, De Iasio R, Montanari P, Mulatero P.
    J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.